{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:16:25Z","timestamp":1790201785809,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1053\/j.semdp.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T08:01:01Z","timestamp":1491552061000},"page":"352-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point"],"prefix":"10.1053","volume":"34","author":[{"given":"Ebru","family":"Linke-Serins\u00f6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2017.04.003_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2016.09.001","article-title":"Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?","volume":"20","author":"Totonchy","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1053\/j.semdp.2017.04.003_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/656416","article-title":"Cancer as a Cause of Death among People with AIDS in the United States","volume":"51","author":"Simard","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semdp.2017.04.003_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.semcancer.2013.08.004","article-title":"Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology","volume":"23","author":"Gloghini","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2017.04.003_bib4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/QAD.0b013e328353f38e","article-title":"Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods","volume":"26","author":"Simard","year":"2012","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"Aids-Associated Non-Hodgkin Lymphoma","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2017.04.003_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.003_bib7","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/cncr.30112","article-title":"Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: analysis of the National Cancer Data Base","volume":"122","author":"Olszewski","year":"2016","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semcancer.2015.03.009","article-title":"Microenvironmental abnormalities induced by viral cooperation: impact on lymphomagenesis","volume":"34","author":"De Paoli","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2017.04.003_bib9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2015-11-681411","article-title":"A lymphomagenic role for HIV beyond immune suppression?","volume":"127","author":"Dolcetti","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00001622-200209000-00009","article-title":"B-cell activation and lymphoma in patients with HIV","volume":"14","author":"Martinez-Maza","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fmicb.2013.00311","article-title":"Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection","volume":"4","author":"Petrara","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1053\/j.semdp.2017.04.003_bib12","doi-asserted-by":"crossref","first-page":"e17831","DOI":"10.1371\/journal.pone.0017831","article-title":"Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells","volume":"6","author":"Giagulli","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2017.04.003_bib13","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.4049\/jimmunol.1502174","article-title":"Germinal center T follicular helper cells are highly permissive to HIV-1 and alter their phenotype during virus replication","volume":"196","author":"Kohler","year":"2016","journal-title":"J Immunol"},{"key":"10.1053\/j.semdp.2017.04.003_bib14","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20101773","article-title":"Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells","volume":"208","author":"Fahey","year":"2011","journal-title":"J Exp Med"},{"key":"10.1053\/j.semdp.2017.04.003_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1208421","article-title":"Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection","volume":"334","author":"Harker","year":"2011","journal-title":"Science"},{"key":"10.1053\/j.semdp.2017.04.003_bib16","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1073\/pnas.1514748112","article-title":"Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis","volume":"112","author":"Dolcetti","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semdp.2017.04.003_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2011.02.007","article-title":"HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies","volume":"305","author":"da Silva","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1053\/j.semdp.2017.04.003_bib18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/JVI.71.1.519-526.1997","article-title":"Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus","volume":"71","author":"Gan","year":"1997","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2017.04.003_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrm1005","article-title":"Entry of viruses through the epithelial barrier: pathogenic trickery","volume":"4","author":"Bomsel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1053\/j.semdp.2017.04.003_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.201108131","article-title":"The cell biology of receptor-mediated virus entry","volume":"195","author":"Grove","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semdp.2017.04.003_bib23","first-page":"5","article-title":"The role of gammaherpesviruses in cancer pathogenesis","author":"Jha","year":"2016","journal-title":"Pathogens"},{"key":"10.1053\/j.semdp.2017.04.003_bib24","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/JVI.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2017.04.003_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-pathol-012513-104656","article-title":"Gammaherpesviruses and lymphoproliferative disorders","volume":"9","author":"Cesarman","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.semcancer.2013.07.005","article-title":"Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas","volume":"23","author":"Dolcetti","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semdp.2017.04.003_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells","volume":"43","author":"Wang","year":"1985","journal-title":"Cell"},{"key":"10.1053\/j.semdp.2017.04.003_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcp.10263","article-title":"Epstein-Barr virus: induction and control of cell transformation","volume":"196","author":"Dolcetti","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semdp.2017.04.003_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/asheducation-2005.1.260","article-title":"Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas","author":"Heslop","year":"2005","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1053\/j.semdp.2017.04.003_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2017.04.003_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2011.03.003","article-title":"Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients","volume":"305","author":"Cesarman","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1053\/j.semdp.2017.04.003_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2017.04.003_bib34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/0046-8177(95)90192-2","article-title":"Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus","volume":"26","author":"Siebert","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1053\/j.semdp.2017.04.003_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/COH.0b013e32831a722b","article-title":"HIV-associated Hodgkin lymphoma","volume":"4","author":"Carbone","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1053\/j.semdp.2017.04.003_bib37","doi-asserted-by":"crossref","first-page":"618760","DOI":"10.4061\/2011\/618760","article-title":"Lymphoproliferative Lesions in the Setting of HIV Infection: a Five-Year Retrospective Case Series and Review","volume":"2011","author":"Mahe","year":"2011","journal-title":"Pathol Res Int"},{"key":"10.1053\/j.semdp.2017.04.003_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.cco.0000432525.70099.a4","article-title":"Pathology of lymphoma in HIV","volume":"25","author":"Cesarman","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.5858\/arpa.2012-0095-RA","article-title":"Lymphoid proliferations associated with human immunodeficiency virus infection","volume":"137","author":"Chadburn","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2017.04.003_bib40","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/emm.2014.82","article-title":"EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management","volume":"47","author":"Ok","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1053\/j.semdp.2017.04.003_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V82.2.619.619","article-title":"In-situ demonstration of epstein-barr-virus small Rnas (Eber-1) in acquired immunodeficiency syndrome-related lymphomas - correlation with tumor morphology and primary site","volume":"82","author":"Hamiltondutoit","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-010-0252-3","article-title":"Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors","volume":"101","author":"Bayraktar","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-14-2083","article-title":"A comparative study of molecular characteristics of diffuse large B-cell Lymphoma from patients with and without human immunodeficiency virus infection","volume":"21","author":"Chao","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2017.04.003_bib44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/CCO.0b013e32834b6adc","article-title":"The management of primary central nervous system lymphoma related to AIDS in the HAART era","volume":"23","author":"Gonzalez-Aguilar","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/PAP.0b013e318229bf08","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly","volume":"18","author":"Adam","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/modpathol.2011.62","article-title":"Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population","volume":"24","author":"Hofscheier","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.semdp.2017.04.003_bib48","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1182\/blood-2010-10-310995","article-title":"A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma","volume":"117","author":"Giulino","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V84.2.397.397","article-title":"Rearrangements of the Bcl-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkins-lymphoma - Association with diffuse large-cell subtype","volume":"84","author":"Gaidano","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib50","first-page":"747","article-title":"Differential expression of BCL-6, CD138\/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas","volume":"91","author":"Carbone","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib51","first-page":"3755","article-title":"Frequent mutation of the 5\u2032 noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas","volume":"89","author":"Gaidano","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib52","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood-2002-11-3606","article-title":"Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma","volume":"102","author":"Gaidano","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib53","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","article-title":"AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib54","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","article-title":"AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?","volume":"116","author":"Guech-Ongey","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib55","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<766::AID-CNCR21>3.0.CO;2-V","article-title":"Burkitt's lymphoma in adults with and without human immunodeficiency virus infection - A single-institution clinicopathologic study of 75 patients","volume":"82","author":"Spina","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib56","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","article-title":"Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas","volume":"16","author":"Davi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ajcp\/103.5.561","article-title":"Aids-related burkitts-lymphoma - morphologic and immunophenotypic study of biopsy specimens","volume":"103","author":"Carbone","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/imr.12067","article-title":"Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals","volume":"254","author":"Moir","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1053\/j.semdp.2017.04.003_bib59","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.05607-11","article-title":"Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection","volume":"85","author":"Haas","year":"2011","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2017.04.003_bib60","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib61","article-title":"Hodgkin's disease and Hiv infection (Hd-Hiv): Prognostic factors in 596 patients (Pts) within the European Group for the study of Hiv and tumours (Gecat)","volume":"22","author":"Spina","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11899-012-0125-2","article-title":"Hodgkin Lymphoma in Patients with HIV Infection: a Review","volume":"7","author":"Martis","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1053\/j.semdp.2017.04.003_bib63","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly Active Antiretroviral Therapy and the Incidence of Non-AIDS-Defining Cancers in People With HIV Infection","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib64","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","article-title":"Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States","volume":"117","author":"Simard","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib65","article-title":"The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis","author":"Carbone","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2017.04.003_bib66","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1182\/blood-2010-08-301531","article-title":"HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4(+) T-cell lymphocytes","volume":"117","author":"Bohlius","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib67","first-page":"2319","article-title":"Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells","volume":"93","author":"Carbone","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib68","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.3883.3883","article-title":"Hodgkin's disease and HIV infection (HD-HIV): Prognostic factors In 596 patients (pts) within the European Group for the study of HIV and tumours (GECAT)","volume":"116","author":"Spina","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib69","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkins-disease and human-immunodeficiency-virus infection - clinicopathological and virological features of 114 patients from the italian cooperative group on aids and tumors","volume":"13","author":"Tirelli","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib70","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/modpathol.2012.217","article-title":"Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma","volume":"26","author":"Hartmann","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1309\/PNVQ0PQGXHVY6L7G","article-title":"HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases","volume":"121","author":"Thompson","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib72","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"Kuppers","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.semdp.2017.04.003_bib74","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib75","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib76","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib77","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib78","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib79","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3324\/haematol.2009.016113","article-title":"Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype","volume":"95","author":"Montes-Moreno","year":"2010","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2017.04.003_bib80","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","author":"Montes-Moreno","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib81","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.21259","article-title":"Plasmablastic lymphoma: one or more entities?","volume":"83","author":"Carbone","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2017.04.003_bib82","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2017.04.003_bib83","doi-asserted-by":"crossref","first-page":"e2014064","DOI":"10.4084\/mjhid.2014.064","article-title":"Current knowledge on HIV-associated Plasmablastic Lymphoma","volume":"6","author":"Bibas","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1053\/j.semdp.2017.04.003_bib84","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib85","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/PAS.0b013e31825e63a9","article-title":"Clinicopathologic Features of B-Cell Lineage Neoplasms With Aberrant Expression of CD3 A Study of 21 Cases","volume":"36","author":"Oliveira","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib86","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":"IG\/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib87","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2010.72","article-title":"Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features","volume":"23","author":"Taddesse-Heath","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib88","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/leu.2015.109","article-title":"Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs","volume":"29","author":"Chapman","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2017.04.003_bib89","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2017.04.003_bib90","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2017.04.003_bib91","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4132\/KoreanJPathol.2014.48.2.81","article-title":"Current concepts in primary effusion lymphoma and other effusion-based lymphomas","volume":"48","author":"Kim","year":"2014","journal-title":"Korean J Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib92","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humpath.2003.11.005","article-title":"Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma","volume":"35","author":"Mate","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib94","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QAD.0b013e3283365395","article-title":"Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines","volume":"24","author":"Carbone","year":"2010","journal-title":"AIDS"},{"key":"10.1053\/j.semdp.2017.04.003_bib95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.anndiagpath.2012.03.004","article-title":"Extracavitary\/solid variant of primary effusion lymphoma","volume":"16","author":"Kim","year":"2012","journal-title":"Ann Diagn Pathol"},{"key":"10.1053\/j.semdp.2017.04.003_bib96","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.24251","article-title":"Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution","volume":"91","author":"Guillet","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2017.04.003_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2372","article-title":"Clinical characteristics and survival outcome of primary effusion lymphoma: a review of 105 patients","author":"El-Fattah","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semdp.2017.04.003_bib98","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5858\/1999-123-0257-HIIPEL","article-title":"Herpesvirus 8 inclusions in primary effusion lymphoma Report of a unique case with T-cell phenotype","volume":"123","author":"Said","year":"1999","journal-title":"Arch Pathol Lab Med"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017300448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257017300448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T04:46:25Z","timestamp":1658897185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257017300448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0740257017300448"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2017.04.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}